Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 2239 entries
Sorted by: Best Match Show Resources per page
Long-term effects of treatment in 374 patients with myasthenia gravis.

Oosterhuis HJ.
PMID: 3173363
Monogr Allergy. 1988;25:75-85.

No abstract available.

Therapeutic plasmapheresis and plasma exchange.

Patten E.
PMID: 3081298
Crit Rev Clin Lab Sci. 1986;23(2):147-75. doi: 10.3109/10408368609165798.

Plasma exchange is a process in which large volumes of plasma, usually equivalent to one plasma volume, are exchanged with donor plasma or a plasma substitute. This permits the removal of antibody, immune complexes, inflammatory mediators, paraproteins, drugs, toxins,...

[Myasthenia gravis before and after thymectomy].

Raue W, Baumann I, Raue I, Schönfelder P.
PMID: 4917029
Neurol Neurochir Pol. 1970 May-Jun;4(3):343-5.

No abstract available.

Treatment of myasthenic crisis in late life.

Sellman MS, Mayer RF.
PMID: 4049040
South Med J. 1985 Oct;78(10):1208-10. doi: 10.1097/00007611-198510000-00017.

In 32 patients with the onset of myasthenia gravis after age 50, myasthenic crisis occurred in 53% and persisted for a mean of 33 days (range six to 84 days). Three of the patients had a second crisis. Precipitating...

Functional difference between cortical and medullar thymic epithelial cells in patients with myasthenia gravis.

Apostolski S, Gospavić J, Isaković K, Mićić M, Popesković L, Stojković M.
PMID: 3474999
Ann N Y Acad Sci. 1987;496:707-10. doi: 10.1111/j.1749-6632.1987.tb35833.x.

No abstract available.

[Thymectomy in the treatment of myasthenia in children].

Kamiński W, Falkowska T.
PMID: 5022930
Pediatr Pol. 1972 Apr;47(4):443-8.

No abstract available.

Thymectomy in myasthenia gravis.

Karbhase JN, Mohire MD, Shah TJ, Bhatt MM, Dewoolkar LV, Desai AD, Parulkar GB.
PMID: 4057119
J Postgrad Med. 1985 Apr;31(2):83-8.

No abstract available.

[Acute myasthenia and its treatment].

Leroy J, Robert M, Delaunay P, Dordain M.
PMID: 5422202
Therapeutique. 1970 Mar;46(3):325-7.

No abstract available.

[Catamnestic examinations in myasthenia].

Prusiński A, Rydzewski W, Kolodziej A, Rościszewska E.
PMID: 5455387
Neurol Neurochir Pol. 1970 May-Jun;4(3):361-4.

No abstract available.

Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.

Pachner AR.
PMID: 3495075
Yale J Biol Med. 1987 Mar-Apr;60(2):169-77.
Free PMC Article

The nicotinic acetylcholine receptor (AChR) is a large membrane protein found in muscle cells. It is involved in the transformation of acetylcholine packets into a membrane depolarization, which thereby leads to a muscle twitch. This large, complex molecule is...

Immunotherapy for myasthenia gravis: a murine model.

Christadoss P, Dauphinee MJ.
PMID: 2419435
J Immunol. 1986 Apr 01;136(7):2437-40.

In vivo therapy with monoclonal antibody (mAb) GK1.5, which recognizes a glycoprotein antigen designated L3T4 on murine helper T lymphocytes, either prevented or suppressed the development of murine lupus, autoimmune encephalomyelitis, and collagen arthritis. The L3T4 antigen in the...

Treatment for refractory myasthenia gravis.

Sakano T, Hamasaki T, Kinoshita Y, Kihara M, Ueda K.
PMID: 2782938
Arch Dis Child. 1989 Aug;64(8):1191-3. doi: 10.1136/adc.64.8.1191.
Free PMC Article

An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immunoglobulin and high dose intravenous methylprednisolone. Ocular symptoms recurred seven months after the start of the immunoglobulin. She has been in remission for more...

Showing 1 to 12 of 2239 entries